SHIRE PHARMACEUTICAL CONTRACTS LIMITED
Company number 02024595
- Company Overview for SHIRE PHARMACEUTICAL CONTRACTS LIMITED (02024595)
- Filing history for SHIRE PHARMACEUTICAL CONTRACTS LIMITED (02024595)
- People for SHIRE PHARMACEUTICAL CONTRACTS LIMITED (02024595)
- Charges for SHIRE PHARMACEUTICAL CONTRACTS LIMITED (02024595)
- Registers for SHIRE PHARMACEUTICAL CONTRACTS LIMITED (02024595)
- More for SHIRE PHARMACEUTICAL CONTRACTS LIMITED (02024595)
| Date (document was filed at Companies House) | Type | Description (of the document filed at Companies House) | View / Download (PDF file, link opens in new window) |
|---|---|---|---|
| 10 Jul 2024 | CS01 | Confirmation statement made on 28 June 2024 with no updates | |
| 19 Feb 2024 | CH01 | Director's details changed for Ms Seyda Atadan Memis on 1 September 2023 | |
| 19 Dec 2023 | AA | Full accounts made up to 31 March 2023 | |
| 07 Jul 2023 | CS01 | Confirmation statement made on 28 June 2023 with updates | |
| 13 Jun 2023 | AA | Full accounts made up to 31 March 2022 | |
| 02 Jun 2023 | TM02 | Termination of appointment of Takeda Corporate Services Limited as a secretary on 31 May 2023 | |
| 10 Mar 2023 | PSC02 | Notification of Takeda Uk Limited as a person with significant control on 21 December 2022 | |
| 10 Mar 2023 | PSC07 | Cessation of Shire Pharmaceuticals Group as a person with significant control on 21 December 2022 | |
| 26 Jan 2023 | TM01 | Termination of appointment of Jonathan Clark Neal as a director on 18 January 2023 | |
| 10 Nov 2022 | TM01 | Termination of appointment of Mark Gibbons as a director on 8 November 2022 | |
| 23 Aug 2022 | AP01 | Appointment of Ms Seyda Atadan Memis as a director on 1 August 2022 | |
| 04 Jul 2022 | CS01 | Confirmation statement made on 28 June 2022 with updates | |
| 19 May 2022 | AA | Full accounts made up to 31 March 2021 | |
| 21 Mar 2022 | AP01 | Appointment of Peter Michael Grubin as a director on 1 March 2022 | |
| 21 Mar 2022 | TM01 | Termination of appointment of Kentaro Shirahata as a director on 1 March 2022 | |
| 11 Nov 2021 | SH19 |
Statement of capital on 11 November 2021
|
|
| 11 Nov 2021 | CAP-SS | Solvency Statement dated 09/11/21 | |
| 11 Nov 2021 | SH20 | Statement by Directors | |
| 11 Nov 2021 | RESOLUTIONS |
Resolutions
|
|
| 09 Jul 2021 | CS01 | Confirmation statement made on 28 June 2021 with no updates | |
| 13 Apr 2021 | AA | Full accounts made up to 31 March 2020 | |
| 01 Dec 2020 | AP01 | Appointment of Mr Kentaro Shirahata as a director on 30 November 2020 | |
| 01 Dec 2020 | AP01 | Appointment of Mr Marc Stuart Page as a director on 30 November 2020 | |
| 01 Dec 2020 | TM01 | Termination of appointment of Nicholas Hugh Meryon Insall as a director on 30 November 2020 | |
| 01 Dec 2020 | TM01 | Termination of appointment of Sarah Lucy Charsley as a director on 30 November 2020 |